LOC105374812: A Potential Drug Target or Biomarker (G105374812)

Target Name: Uncharacterized LOC105374812, transcript variant X2

NCBI ID: G105374812

Uncharacterized LOC105374812, transcript variant X2

Other Name(s): LOC105374812 variant X2

LOC105374812: A Potential Drug Target or Biomarker

LOC105374812 is a gene located on chromosome 10q34.3 has been identified as a potential drug target or biomarker. It has been shown to be involved in various cellular processes that are crucial for cell survival and growth. This gene has not been well characterized, and its functions and potential drug targets are still being explored. In this article, we will discuss the characterization of LOC105374812 and its potential implications as a drug target or biomarker.

LOC105374812: A Potential Drug Target

LOC105374812 has been shown to be involved in various cellular processes that are crucial for cell survival and growth. It is a gene that has been associated with the development and progression of various diseases, including cancer. Several studies have shown that LOC105374812 is involved in the regulation of cell cycle progression, apoptosis, and angiogenesis.

One of the key features of LOC105374812 is its role in the regulation of the cell cycle. It has been shown to be involved in the G1/S transition, which is a critical step in the cell cycle that leads to the entry of the cell into the S phase. The G1/S transition is also known as the G0/G1 checkpoint, and it is a critical step in the regulation of cell growth and apoptosis.

In addition to its role in the cell cycle, LOC105374812 has also been shown to be involved in apoptosis. Apoptosis is a natural process that is essential for the elimination of damaged or dysfunctional cells. LOC105374812 has been shown to be involved in the regulation of apoptosis, which is a critical process that helps remove damaged cells from the body.

Another function of LOC105374812 is its role in angiogenesis. Angiogenesis is the process by which new blood vessels are formed in the body. LOC105374812 has been shown to be involved in the regulation of angiogenesis, which is a critical process that helps the body repair damaged blood vessels.

Potential Biomarker

LOC105374812 has also been shown to have potential as a biomarker for various diseases. The identification of LOC105374812 as a potential biomarker for diseases has led to further research into its functions and potential uses.

One of the key potential uses of LOC105374812 is its potential as a drug target. The regulation of cell cycle progression, apoptosis, and angiogenesis are critical processes that are involved in the development and progression of various diseases, including cancer. By targeting LOC105374812, researchers may be able to develop new treatments for these diseases.

Another potential use of LOC105374812 is its potential as a biomarker for disease diagnosis. The regulation of cell cycle progression, apoptosis, and angiogenesis is a critical process that is involved in the development and progression of various diseases. By measuring the expression of LOC105374812, researchers may be able to diagnose diseases that are caused by disruptions in these processes.

Conclusion

LOC105374812 is a gene that has not been well characterized. However, its involvement in various cellular processes that are crucial for cell survival and growth makes it a potential drug target or biomarker. Further research is needed to fully understand the functions of LOC105374812 and its potential implications as a drug target or biomarker.

Protein Name: Uncharacterized LOC105374812, Transcript Variant X2

The "Uncharacterized LOC105374812, transcript variant X2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Uncharacterized LOC105374812, transcript variant X2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets